Characterization of histamine release from the rat hypothalamus as measured by in vivo microdialysis

Yoshinori Itoh, Ryozo Oishi, Masahiro Nishibori, Kiyomi Saeki

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

The release of endogenous histamine (HA) from the hypothalamus of anesthetized rats was measured by in vivo microdialysis coupled with HPLC with fluorescence detection. Freshly prepared Ringer's solution was perfused at a rate of 1 μl/min immediately after insertion of a dialysis probe into the medial hypothalamus, and brain perfusates were collected every 30 min into microtubes containing 0.2 M perchloric acid. The basal HA output was almost constant between 30 min and 7 h after the start of perfusion, with the mean value being 7.1 pg/30 min. Thus, the extracellular HA concentration was assumed to be 7.8 nM, by a calculation from in vitro recovery through the dialysis membrane. Perfusion with a high K+ (100 mM)-containing medium increased the HA output by 170% in the presence of Ca2+. Systemic administration of either thioperamide (5 mg/kg, i.p.), a selective H3 receptor antagonist, or metoprine (10 mg/kg, i.p.), an inhibitor of HA-N-methyltransferase, caused an approximately twofold increase in the HA output 30-60 min after treatment. The combined treatment with thioperamide and metoprine produced a marked increase (650%) in the HA output. The HA output decreased by ∼70% 4-5 h after treatment with α-fluoromethylhistidine (α-FMH; 100 mg/kg, i.p.), an inhibitor of histidine decarboxylase. Furthermore, the effect of combined treatment with thioperamide and metoprine was no longer observed in α-FMH-treated rats. These results suggest that both HA-N-methyltransferase and H3 autoreceptors are involved in maintaining a constant level of extracellular HA and that their blockade effectively results in a higher activity level of the endogenous histaminergic system in the CNS.

Original languageEnglish
Pages (from-to)769-774
Number of pages6
JournalJournal of Neurochemistry
Volume56
Issue number3
Publication statusPublished - 1991

Fingerprint

Histamine Release
Microdialysis
thioperamide
Histamine
Hypothalamus
Rats
Histamine N-Methyltransferase
Dialysis
Perfusion
Histamine H3 Receptors
Histidine Decarboxylase
Middle Hypothalamus
Dialysis membranes
Autoreceptors
Fluorescence
High Pressure Liquid Chromatography
Brain
Membranes
Recovery
metoprine

Keywords

  • H receptors
  • Histamine
  • Histamine-n-methyltransferase
  • Hypothalamus
  • Microdialysis
  • Rat

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Characterization of histamine release from the rat hypothalamus as measured by in vivo microdialysis. / Itoh, Yoshinori; Oishi, Ryozo; Nishibori, Masahiro; Saeki, Kiyomi.

In: Journal of Neurochemistry, Vol. 56, No. 3, 1991, p. 769-774.

Research output: Contribution to journalArticle

@article{909894a38f4e4ba6b885344fb7a296c8,
title = "Characterization of histamine release from the rat hypothalamus as measured by in vivo microdialysis",
abstract = "The release of endogenous histamine (HA) from the hypothalamus of anesthetized rats was measured by in vivo microdialysis coupled with HPLC with fluorescence detection. Freshly prepared Ringer's solution was perfused at a rate of 1 μl/min immediately after insertion of a dialysis probe into the medial hypothalamus, and brain perfusates were collected every 30 min into microtubes containing 0.2 M perchloric acid. The basal HA output was almost constant between 30 min and 7 h after the start of perfusion, with the mean value being 7.1 pg/30 min. Thus, the extracellular HA concentration was assumed to be 7.8 nM, by a calculation from in vitro recovery through the dialysis membrane. Perfusion with a high K+ (100 mM)-containing medium increased the HA output by 170{\%} in the presence of Ca2+. Systemic administration of either thioperamide (5 mg/kg, i.p.), a selective H3 receptor antagonist, or metoprine (10 mg/kg, i.p.), an inhibitor of HA-N-methyltransferase, caused an approximately twofold increase in the HA output 30-60 min after treatment. The combined treatment with thioperamide and metoprine produced a marked increase (650{\%}) in the HA output. The HA output decreased by ∼70{\%} 4-5 h after treatment with α-fluoromethylhistidine (α-FMH; 100 mg/kg, i.p.), an inhibitor of histidine decarboxylase. Furthermore, the effect of combined treatment with thioperamide and metoprine was no longer observed in α-FMH-treated rats. These results suggest that both HA-N-methyltransferase and H3 autoreceptors are involved in maintaining a constant level of extracellular HA and that their blockade effectively results in a higher activity level of the endogenous histaminergic system in the CNS.",
keywords = "H receptors, Histamine, Histamine-n-methyltransferase, Hypothalamus, Microdialysis, Rat",
author = "Yoshinori Itoh and Ryozo Oishi and Masahiro Nishibori and Kiyomi Saeki",
year = "1991",
language = "English",
volume = "56",
pages = "769--774",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Characterization of histamine release from the rat hypothalamus as measured by in vivo microdialysis

AU - Itoh, Yoshinori

AU - Oishi, Ryozo

AU - Nishibori, Masahiro

AU - Saeki, Kiyomi

PY - 1991

Y1 - 1991

N2 - The release of endogenous histamine (HA) from the hypothalamus of anesthetized rats was measured by in vivo microdialysis coupled with HPLC with fluorescence detection. Freshly prepared Ringer's solution was perfused at a rate of 1 μl/min immediately after insertion of a dialysis probe into the medial hypothalamus, and brain perfusates were collected every 30 min into microtubes containing 0.2 M perchloric acid. The basal HA output was almost constant between 30 min and 7 h after the start of perfusion, with the mean value being 7.1 pg/30 min. Thus, the extracellular HA concentration was assumed to be 7.8 nM, by a calculation from in vitro recovery through the dialysis membrane. Perfusion with a high K+ (100 mM)-containing medium increased the HA output by 170% in the presence of Ca2+. Systemic administration of either thioperamide (5 mg/kg, i.p.), a selective H3 receptor antagonist, or metoprine (10 mg/kg, i.p.), an inhibitor of HA-N-methyltransferase, caused an approximately twofold increase in the HA output 30-60 min after treatment. The combined treatment with thioperamide and metoprine produced a marked increase (650%) in the HA output. The HA output decreased by ∼70% 4-5 h after treatment with α-fluoromethylhistidine (α-FMH; 100 mg/kg, i.p.), an inhibitor of histidine decarboxylase. Furthermore, the effect of combined treatment with thioperamide and metoprine was no longer observed in α-FMH-treated rats. These results suggest that both HA-N-methyltransferase and H3 autoreceptors are involved in maintaining a constant level of extracellular HA and that their blockade effectively results in a higher activity level of the endogenous histaminergic system in the CNS.

AB - The release of endogenous histamine (HA) from the hypothalamus of anesthetized rats was measured by in vivo microdialysis coupled with HPLC with fluorescence detection. Freshly prepared Ringer's solution was perfused at a rate of 1 μl/min immediately after insertion of a dialysis probe into the medial hypothalamus, and brain perfusates were collected every 30 min into microtubes containing 0.2 M perchloric acid. The basal HA output was almost constant between 30 min and 7 h after the start of perfusion, with the mean value being 7.1 pg/30 min. Thus, the extracellular HA concentration was assumed to be 7.8 nM, by a calculation from in vitro recovery through the dialysis membrane. Perfusion with a high K+ (100 mM)-containing medium increased the HA output by 170% in the presence of Ca2+. Systemic administration of either thioperamide (5 mg/kg, i.p.), a selective H3 receptor antagonist, or metoprine (10 mg/kg, i.p.), an inhibitor of HA-N-methyltransferase, caused an approximately twofold increase in the HA output 30-60 min after treatment. The combined treatment with thioperamide and metoprine produced a marked increase (650%) in the HA output. The HA output decreased by ∼70% 4-5 h after treatment with α-fluoromethylhistidine (α-FMH; 100 mg/kg, i.p.), an inhibitor of histidine decarboxylase. Furthermore, the effect of combined treatment with thioperamide and metoprine was no longer observed in α-FMH-treated rats. These results suggest that both HA-N-methyltransferase and H3 autoreceptors are involved in maintaining a constant level of extracellular HA and that their blockade effectively results in a higher activity level of the endogenous histaminergic system in the CNS.

KW - H receptors

KW - Histamine

KW - Histamine-n-methyltransferase

KW - Hypothalamus

KW - Microdialysis

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=0026101040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026101040&partnerID=8YFLogxK

M3 - Article

VL - 56

SP - 769

EP - 774

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -